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Working capital management in the Swiss
chemical industry
daily operations and the short run funding needs
of a company. Improvements within the working
capital levels thus offer various benefits, like
lower capital requirements and lower capital
costs, but also optimized supply chains and
operational excellence. Eventually, these changes
lead to higher profitability and to competitive
advantages.
The origin of working capital
The operating cycle is composed of the inventory
period and the accounts receivable period place
(Ross et al., 2008). The inventory period is the
average amount of time the inventory is held,
whereas the receivables period is the average
number of days it takes from the sale of the
goods until the cash receipt from the customer.
The accounts payable period, in turn, is the
average time span between the purchase of the
raw materials and the cash outflow to the
supplier.
The difference between the operating cycle and
the accounts payable period is called the cash
cycle. It is the time period it takes on average
from the cash outlay by the firm to the suppliers
to the cash inflow from the customer. In other
words, it shows the financing needs of a
company regarding the operating activities,
since part of the inventory and accounts
receivable have to be financed by either
borrowing money or holding a liquidity reserve
(Farris and Hutchison, 2003). The amount of this
additional financing depends on the length of
the cash cycle: the longer the cash cycle is, the
higher are the capital requirements and vice
versa (Boer, 1999). This is due to the fact that
the longer a firm has to wait after the cash
outflow to the supplier to the cash inflow from
the customer, the longer it has to finance the
operations through other sources.
Introduction
The performance of Swiss based chemical and
pharmaceutical companies regarding their working
capital management and its underlying
components, namely accounts receivable, inventories
and accounts payable differs over time and between
the single firms. The calculation of a cash potential
for the year 2008 shows that 17 billion CHF is tied
up in the companies’ balance sheets if they would
realise the Swiss best practice performance. It has
also been shown that in recent years Swiss chemical
and pharmaceutical companies have a considerably
higher working capital level compared to their
European and US peers. The managerial implications
for the achievement of best practice are the
awareness of the top management, efficient
processes on the operating level as well as an
enhanced collaboration within the company as well
as throughout the entire supply chain.
The need for operational excellence
The chemical and pharmaceutical sectors are
facing significant changes: the ongoing
consolidation in the supplier, competitor and
customer base, as well as the proceeding
globalization is posing numerous challenges.
Moreover, the increasing price competition and
rising feedstock prices bring margins under
pressure and force the chemical and
pharmaceutical firms to seek for ways to oppose
those trends. Working capital optimizations offer
various opportunities, both in the short as well
as in the long run. The working capital mainly
comprises accounts receivable, inventories and
accounts payable. These three balance sheet
entries are the immediate financial picture of
a company’s operating activities. At this point
the relevance of the working capital becomes
obvious: it lies at the interface between a firm’s
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whether a company is able to meet its currently
maturing financial obligations by its currently
maturing short-term assets, and hence examine
a firm’s liquidity.
In order to incorporate the dynamic nature
of a firm’s business the working capital ratios
and the cash cycle are becoming more popular
(Losbichler and Rothböck, 2008).  The Days
Working Capital ratio (DWC, also called cash
conversion cycle or cash-to-cash cycle) expresses
the cash cycle in terms of days, and is calculated
based on the lengths of the underlying periods,
which are depicted in Fig. 1.
The days sales outstanding ratio (DSO)
converts the receivables period into days (Brealey
and Myers, 2005):
......
Accounts Receivable..* 365 = 
Accounts Receivable
DSO = ........Sales ................................Average Daily Sales
The DSO measures how many days it takes
on average from the sale of the goods until the
customers pay their bills. A high DSO leads to a
longer cash cycle, and hence also to higher
working capital levels.
The days inventory outstanding (DIO) denotes
the average time span in terms of days for a
good to be purchased as raw material, converted
into the finished good, and finally sold to the
customer:
The connection between the operating activities
and the financing needs of a company becomes
more obvious when considering its impacts on
the balance sheet. The length of the operating
cycle determines the actual inventory and
accounts receivables levels and hence
considerably affects the amount of current assets
which is held by the company. On the other hand,
the length of the ac-counts payable period has
a substantial impact on the level of a firm’s
current liabilities, namely the amount of
accounts payable. The capital needs, with respect
to the operating activities are finally determined
by taking the difference between the sum of
the accounts receivable and the inventories
minus the accounts payable. This difference is
called the net working capital and corresponds
to a company’s short run financing needs
(Wagner and Locker, 2008).
Measuring the working capital
Various ratios can be used in order to evaluate
a company’s short term assets and liabilities.
Well-known examples are the liquidity ratios
like the current and the quick ratio (Volkart,
2006). These ratios focus on a firm’s short-term
solvency, since they provide an indication of how
well the short-term liabilities are covered by
short-term assets. In other words, they indicate
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Figure 1 Operating and cash cycle
Source: Own elaboration, based on Ross et al., 2008
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Inventory Outstanding and Days Payable
Outstanding represent the metric for the
assessment of accounts receivable, inventories
and accounts payable, respectively. The Days
Working Capital ratio is considered as measure
for the overall examination of the working
capital levels, i.e. providing the collaborative
working capital view. Year-end balance sheet
entries have been used for the calculations of
all ratios.
The sample consists of 18 companies that are
listed at the SIX Swiss Exchange and
headquartered in Switzerland. Furthermore,
firms were chosen according to the Standard
Industrial Classification (SIC) system: only
corporations classified as Chemicals & Allied
Products (SIC Code 2800) and its sub-segments
were considered. Based on those requirements,
the study includes the following eighteen firms: 
Actelion Ltd., Bachem Holding AG, Ciba
AG (now part of BASF), Clariant AG, CPH
Chemie & Papier Holding AG, Dottikon ES
Holding AG, Ems-Chemie Holding AG,
Galenica AG, Givaudan SA, Gurit Holding AG,
Lonza Group AG, Novartis AG, Quadrant AG,
Roche Holding AG, Acino Holding AG
(formerly Schweizerhall Holding AG), Siegfried
Holding AG, Sika AG, Syngenta AG
Outliers (mainly start-up companies) have
been excluded in order to provide a more
accurate view. 1 The five firms below are not
considered for the survey:
Arpida AG, Basilea Pharmaceutica AG,
Cytos Biotechnology AG, Santhera
Pharmaceuticals Holding AG, Speedel Holding
AG
The starting data, namely the year-end
figures of the accounts receivable, inventories,
accounts payable, and sales, was taken from the
THOMSON REUTERS OneBanker data base. The
working capital performance metrics are thus
calculated based on publicly available financial
statements issued by the companies. Although
the study focuses on firms headquartered in
Switzerland, the individual figures correspond
to their respective global values.
values.
Receivables performance
There is no clear trend regarding receivables
performance within the last eight years: the
Days Sales Outstanding (DSO) median followed
a very volatile path and there have been great
......
Inventory..* 365 = 
       Inventory                   .DIO = .....Sales ..............Average Daily Sales
The sum of the DSO and DIO result in the
operating cycle. Therefore, an increase in these
ratios leads also to an increase in the cash cycle.
The day‘s payable outstanding (DPO)
expresses the average number of days a
company waits until it pays its suppliers:
......
Accounts Payable..* 365 = 
Accounts Payable.DPO= .............Sales .............. Average Daily Sales
Since the cash cycle is the difference between
the operating cycle and the payables period, an
in-crease in the DPO results in a shorter cash
cycle. Hence, the later the cash outflows to the
suppliers occur, the less capital is needed to
finance the operating activities of a company.
The Days Working Capital is calculated by
putting these ratios together:
DWC = Days Sales Outstanding + Days Inventory Out
....... ......standing – Days Payable Outstanding
The cash conversion cycle thus measures the
average time span between the cash outflow
for the purchase of inventories and the cash
inflow from the collection of receivables.
The importance of an efficient working
capital management is confirmed by several
studies (e.g. Jose et al., 1996 or Shin and Soenen,
1998), which show that a shorter cash cycle leads
to higher profitability and rising share prices
thus, resulting in an increased enterprise value.
The working capital survey of the Swiss
chemical industry
The survey is aimed to reveal the working
capital performance of Swiss based chemical
and pharmaceutical companies within recent
years. Moreover, general trends and peculiarities
of the chemical sector are presented and the
corresponding drivers and causes are identified.
In addition to this quantitative approach, a
questionnaire was forwarded to all investigated
companies in order to evaluate the awareness
and relevance of an efficient working capital
management for the firms and the responsible
executives.
Research methodology and scope
The ratios Days Sales Outstanding, Days
1) Start-up companies usually are quickly expanding and have less constant sales volumes. Therefore, working capital levels and turnovers sometimes vary considerably from year
to year, and hence also the measured ratios (DSO, DIO, DPO and DWC). Furthermore, since those firms are growing very fast, the processes are not very harmonized and thus not
suited for comparisons with established companies.
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to a geographical shift of the customer base,
mainly to Eastern European and Asian countries.
That entailed changing customer relationships
and threatened established supply chains.
Probably, the management did not want to
endanger those sensitive relationships by forcing
stricter payment terms.
Inventory performance
A lean inventory leads to less tied-up capital
and less inventory costs. Therefore, a lower Days
Inventory Outstanding (DIO) ratio leads to less
capital requirements and higher profitability.
The Days Inventory Outstanding (DIO) median
value has improved over the whole period by
11%, since it has decreased by 7 days from 64
days in 2001 down to 57 days in 2008. Despite
this respectable overall lowering in inventory
levels, the study results imply no constant and
ongoing improvements for the whole sector: in
fact, the DIO median has risen in years 2001 to
2003, substantially declined in year 2004, but
has stayed almost unchanged until 2008.
However, there has been a decrease of 3 days in
2008, which at least shows a positive trend in
the recent past.
As mentioned above, the economy was
slowing down in years 2001 to 2004, and it is
likely that this downturn has led to an
optimization within the inventories. The
companies reduced its stocks in the light of
fluctuations even between certain single years,
as displayed in Fig. 2. Overall, the DSO median
has deteriorated within the last eight years by
5 days from 65 days in 2001 to 70 days in 2008.
That corresponds to an increase of 8%.
The greatest increase occured during 2005,
when the median went up by 19%, in accordance
with the fact three quarters of the firms
displayed a higher DSO value in 2005 compared
to 2004. In the light of this industry-wide
deterioration, it seems that there existed
external causes which put pressure on the entire
sector. Actually, the economic circumstances
were hard in the years 2000 to 2005: the Swiss
economy was suffering heavily from the impacts
and aftermath of the Dotcom bubble. The
recovery of the economy in the third quarter of
2005 is likely to be the cause of the rise in DSO.
The chemical and pharmaceutical companies
have probably tried to achieve more sales volume
and to bind their customers by agreeing to less
rigorous payment terms and hence longer
payment periods. 
The trends towards consolidation and
globalization supposedly are other factors that
have caused stagnating or even rising DSO
figures: the consolidation phase has led to bigger
customers in terms of sales volume. It is likely
that the power has shifted to the buyers and
that more pressure is put on the suppliers in
order to negotiate longer payment terms (Budde
et al., 2006). Moreover, the globalization has led
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the inventory level with the daily sales, the
relationship becomes apparent: only if the sales
volume increases equally to the inventory level,
in relative terms, the DIO will stay the same.
However, that not only requires a full shift of
the higher costs to the customer, but also the
same sales volume in terms of units despite the
price increase. It is likely that most of the
companies have not been able to fully pass on
those increases to their customers in the short-
run.4 Therefore, the rise in feedstock prices most
probably had a negative influence on the
industry’s inventory performance, except for the
year 2008. On the other hand, the considerable
fall in the oil price in 2008 might partly have
caused the decreasing DIO figures for the
median.
Payables performance
In contrast to the DSO and the DIO, a higher
Days Payable Outstanding (DPO) ratio leads to
lower net working capital levels. In other words:
rising DPO ratios mean an improvement,
whereas falling DPO ratios indicate deterioration.
The DPO median exhibits an overall upward
trend, with a temporary downfall in the years
2005 and 2006. Overall, it has increased by 5.5
days or 22% from 24 days in 2001 up to 29 days
in 2008. In the year 2008 however, the median
again has fallen by 2 days, which means a
negative tendency for the recent past. The
economic circumstances seem to play an
important role also with regard to the payables
performance. The median increases in years 2001
to 2004, which leads to the assumption that
the companies have stretched their accounts
payable by later payments to their suppliers.
This is in accordance with the fact that the
median has declined in 2005, when the economy
experienced an upturn. The median decreased
in 2008 after an increase in 2007. Since the raw
material prices have risen sharply in 2007 and
the first half of 2008, it is likely that the
companies have recently focused on the price
rather than on the payment terms. 
As mentioned above, the sector has
experienced a consolidation and globalization
phase (Jakobi, 2001). Whereas those trends can
threaten the receivables performance, it also
provides chances regarding the payables
performance. The increasing size of the firms
within the chemical and phar-maceutical
decreasing sales and bad business prospects.
That led to declining DIO values across the entire
industry. However, although the economy
recovered in the second half of 2005, the DIO
median shows no considerable increase. The
companies obviously have been able to increase
their sales by keeping the production lean. In
2008, the decrease in the median might be again
partly due to the bad business outlook.
Furthermore, a study of the consulting
company KPMG (KPMG, 2008) has stated that
most of the improvements regarding the
inventory management were most likely
achieved through a
“[…] continual investment in the
manufacturing process to improve yields,
remove bottlenecks and accelerate production.”
KPMG mentions in the same report that the
companies have tried to transfer the
responsibility of the raw material inventory to
the suppliers. That happened for example
through the creation of consignment stocks2,
and hence led to lower inventory levels in the
firms’ balance sheets.
The two main trends stated in the DSO
chapter, consolidation and globalization, also
give rise to new challenges with regard to the
inventory management. Supply chains are
becoming more and more international, e.g.
through the outsourcing of certain activities or
the global purchase of raw materials, resulting
in a lengthening of the supply chains
(Christopher, 2008). Moreover, new supply chains
arising from mergers and acquisitions have to
be developed and integrated.
Another impact on the inventory
performance originated from the constantly
rising raw material prices, like crude oil, natural
gas and petrochemicals. Not surprisingly, the
chemical industry suffered more from increasing
oil prices than other industries. The high oil
dependency lies in the nature of the chemical
and pharmaceutical production: oil is the basis
of virtually every organic product. A price
inflation in raw materials leads to higher
inventory levels in monetary terms, because the
same amount of stock keeping units has a higher
value.3 The effect of the rising feedstock prices
on the inventory performance, measured by the
DIO, partly depends on a company’s ability to
pass on these higher costs to its customers,
namely through price increases of the products
(Ernst & Young, 2008). Since the DIO compares
2) Inventories held in a consignment stock belong to the supplier until the customer uses them. In other words, the stock legally belongs to the supplier, but it is held by the
customer. The customer has the advantage that the stock is stored at the production site, but the inventories do not appear in its balance sheet.
3) This is true for the raw material fraction of the inventory. The valuation of the WIP and finished goods may also depend on market prices.
4) Since a firm’s negotiation position is enhanced when the raw material prices are staying at higher levels, it is more likely that the higher costs can be passed on to the customers
in the long run. The effect on the inventory performance should therefore be mitigated in the long term.
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industry, resulting from various mergers and
acquisitions, increases the supplier’s dependency
on the customer, and leads to more power for
the buying firm with regard to the negotiations
of payment terms.
Nevertheless, the overall rise is probably also
partially caused by the price inflation of the raw
materials. The mechanism is the same as for the
DIO ratio: the increasing feedstock prices lead
to higher accounts payable. Since it is not likely
that the entire increase in raw material costs
has been transferred to the customers, the rise
in DPO is probably partially caused by the rising
feedstock prices.
Collaborative working capital management
performance
The Days working capital (DWC) ratio is used as
a measure of the overall working capital
manage-ment performance. The DWC combines
the values of the different working capital
components (DSO, DIO, and DPO), and serves as
a measure of a company’s net working capital
level in general.
The DWC median shows a clear downward trend
within the last eight years and hence, the
working capital levels have been lowered overall.
Since 2001, the industry’s median has decreased
by 17.5 days from 111 days in 2001 to 93.5 days in
2008, an improvement of 16%. This is supported
by the fact that eleven firms out of eighteen
exhibit a lower Days Working Capital ratio in
2008 than in 2001.
Since the collaborative working capital measure
DWC is composed of the underlying components’
ratios DSO, DIO and DPO, the DWC evolution is
the result of the evolution of the single
underlying ratios. Hence, changes in DSO, DIO
or DPO cause a change in DWC. As described
above, the economic situation has a big influence
on the single components of the working capital.
The same is true for the DWC median, which
has decreased during the years 2001 to 2004,
when the economic circumstances were difficult.
It increased in 2004 when the economy was
recovering, and declined again in the years
afterwards. This connection implies that the
firms are focusing on working capital
management in times of difficult economic
conditions and somehow neglect an efficient
working capital structure in times of an upturn.
Since it is harder to generate profits or obtain
credits when the economy is slowing down,
companies try to run their businesses by internal
funding and improve the operating results
through even stricter cost reduction programs.
On the other hand, the firms focus more on
market share and gaining sales volume during
promising economic outlooks, and hence set
different priorities, which leads to a losing focus
on the cash cycle.
However, the amounts of net working capital
have been lowered again after the achievement
of the new production level in the years 2006
and 2007, when the firms have been
accommodating with the new output level. In
2008, the DWC median once more declines
considerably, as the economic forecasts became
pessimistic due to the starting financial crisis.
It seems that the firms again tried to mitigate
that impact partly by improving their working
capital balances.
Other drivers for a general improvement with
regard to the working capital emerge from
changes of traditional business circumstances:
especially the pharmaceutical sector has
historically displayed high profit margins and
strong balance sheets, what usually has led to
a comparably facile access to new funds (Sage
2009). Furthermore, pharmaceutical companies
tended to hold high safety stocks, since stock-
outs of essential drugs lead to a bad image and
the loss of the customers’ trust. In the light of
these circumstances, pharmaceutical companies
traditionally have operated with comparably
high working capital levels and have experienced
low pressure for improvements within this area.
However, that comfortable state has been
jeopardized in recent years by decreasing
margins, reduced growth opportunities and less
productive outcomes in drug discoveries. These
unfavorable developments have forced the
pharmaceutical firms to seek for ways to oppose
those trends.
The picture is similar for the chemical industry,
which is facing on one hand rising costs, mainly
due to the increase of the raw material prices
(Budde et al., 2006). On the other hand, the
chemical sec-tor experiences a permanent price
pressure, originating from increased competition,
for example through the entrance of new, mostly
Asian players. Therefore, the chemical industry
is struggling heavily with maintaining the actual
level of return on investment (ROI). It is likely
that those external pressures have caused the
companies to seek for new opportunities to
counter these negative trends. Since an
optimization of the working capital and its
related practices leads to higher access to cash5,
lower costs, lower capital requirements and also
to higher sales growth (Losbichler and Rothböck,
5) For example through a better access to credit and through earlier cash inflows.
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focused on the entire sector. The working capital
levels for the individual companies are depicted
in Fig. 3. In the DWC portfolio, the Days Working
Capital (DWC) ratio in 2008 is compared to the
relative change of the DWC since 2004. The
interception of the axes is at the DWC median
of 2008, at 94 days, and at the median of the
changes since 2004, at -1.6%.
Therefore, companies lying in the first
quadrant have a high DWC ratio in 2008 and
have shown a change less than the industry’s
median within the last five years. In the opposite
quadrant, the third one, firms within that
quadrant have a comparably low DWC value in
the year 2008, and have still been able to further
reduce their accounts receivable relative to sales
volume. The second quadrant includes
corporations that have a DWC lower than the
industry’s median in 2008, but which have
experienced a change less than the median
within the last five years. Finally, companies
within the fourth quadrant have a DWC which
is higher than the industry’s median in 2008,
but those firms have reduced their DWC since
2004 to a higher extent than the median value.
It becomes evident that Quadrant, Gurit, Ems
Chemie, Schweizerhall and Sika are not only
among the companies with the lowest DWC in
2008), it is likely that chemical and
pharmaceutical firms have tried to take
advantage of that leverage in recent years. As
mentioned above, the pharmaceutical sector
historically operates with high working capital
levels. It is therefore very likely that they have
tried to enhance their performance through
leaner working capital practices.
This conclusion is supported by a study
concerning the life sciences industry carried out
by the con-sulting firm Ernst & Young (Ernst &
Young, 2009), which states that
“within the last year (2008, note from the
authors), the number of initiatives launched by
com-panies to free up cash has risen sharply.”
Last but not least, the further emergence and
development of IT systems have enabled
companies to improve their data management
and enhance their processes and planning
accuracies. Due to new and better possibilities
arising from the progress in the information
technology, the companies are provided with
tools for more accurate and resilient planning
and controlling outcomes.
The companies’ perspective
The discussion of the results so far has
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Figure 3 DWC Portfolio: Current vs. past performance
Source: Own elaboration, based on publicly available financial statements
* For Dottikon, the change since 2005 is considered, because it went public in 2005
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compared to each other, but also to the
performance of chemical and pharmaceutical
firms based in Europe and the US.
The median values for the different ratios
and regions are depicted in Fig. 4. It becomes
apparent that the Swiss sector displays higher
median values than the European and the US
sector for all the ratios and years, except for the
DPO. With regard to the DSO median, the gap
amounts to approx-imately 20 days to the US
median and 10 days to the European median in
2008. The difference be-tween the Swiss DIO
median and the US median is 16 days, and 11
days between the Swiss and the European one.
The Swiss companies are only performing better
than the US ones regarding the DPO median:
the Swiss median lies 4 days above the US one,
but is still 2 days lower than the European one.
The performances in the single components,
especially with regard to the DSO and DIO ratios,
lead also to a comparably high Days Working
Capital median of 94 days in 2008. It is 19 days
higher than the European median, and 21 days
higher than the US median.
This comparison shows that Swiss based
companies are performing on a higher Working
Capital level than their European and US
competitors on a median basis. In fact, the
median Swiss company holds almost one fourth
more net working capital relative to the sales
volume than its US counterpart, and one fifth
more than its European counterpart. Hence,
Swiss based companies are keeping considerably
higher amounts of tied-up capital that is related
to the working capital within their balance
sheets. That in turn means that Swiss companies
are operating less efficiently than its foreign
competitors with regard to their short-term
assets and funds and that they could generate
a higher shareholder value by adapting the
working capital practices of US and European
firms (Losbichler and Rothböck, 2008).
Results of the questionnaire
In addition to the quantitative examination
of the working capital performance through the
analysis of the companies’ financial statements,
a questionnaire was forwarded to each company
(except for Ciba6 ) to obtain some qualitative
data. The aggregated results of that survey are
intended to give a bigger picture of the relevance
of the working capital management for the
firms. Nine companies out of seventeen
answered the questionnaire.
2008, but show also the biggest improvement
within the last five years. Bachem, Siegfried and
Dottikon, on the other hand, have high working
capital levels relative to sales in 2008, and have
even seen deterioration compared to 2004. They
are thus located at the upper right side of the
portfolio.
The amazingly great gap in DWC between
the companies in 2008 of 242 days reveals huge
differences in working capital management
within the industry. The fact that ten out of
eighteen companies have been able to reduce
their working capital level in the last five years
confirms that it is possible to take advantage
of the potential which is lying in the accounts
receivable, inventories and accounts payable.
Cash potential amounts to CHF 17 billion in
2008
As shown above, the firms within the
chemical sector hold different levels of working
capital relative to their respective sales volume.
By lowering those current assets or increasing
the short-term liabilities, companies can reduce
their capital and free up cash. The cash potential
is calculated by comparing the average net
working capital to sales ratio of companies
within the first quartile with the actual net
working capital to sales ratio of the firms of the
upper three quartiles. The companies in the first
quartile (in this case Quadrant, Galenica, Gurit,
Schweizerhall and Sika) are taken as reference
values and hence have no cash potential in this
calculation. All other companies are compared
to the average of the 25% best performing firms,
which amounts to 17.2% for the year 2008. The
difference between a firm’s NWC to sales ratio
and the benchmark taken from the first quartile
results in the company’s cash potential. It is thus
that amount of cash which would be freed up
if the company reduced its NWC relative to sales
to the average of the first quartile, instead of
holding the actual level. For the entire sector,
the cash potential amounts to CHF 17 billion in
2008, this is equal to 13.2% of annual sales of
the companies in the upper three quartiles.
Performance compared to European and US
competitors
Swiss chemical and pharmaceutical
companies are operating in a global environment
and hence are facing global competition. It is
therefore reasonable that they are not only
6) Ciba has been acquired by BASF in 2008, and is fully integrated since April 2009.
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the other hand, the firms see a lower impact on
the profitability in the short-run, with an average
rating of 3.22 out of 5. This might reflect the fact
that the actions taken for the improvement of
the working capital first cause certain one-time
costs and the benefits of the reduction in the
WC levels occur later, in the long-run.
Concerning the potential for improvements,
the companies were asked to rate the different
levels of potential again on a scale from 1 to 5.
The higher the number in the rating, the higher
is the potential seen by the companies.
With seven companies out of nine stating
that they see a potential of 3 and higher, most
of the firms detect opportunities for
improvements within the working capital
management in general. Whereas the companies
see the highest potential in accounts receivable
and inventories, with an average potential of
4.25, the lowest potential is seen in accounts
payable, with an average of 2.875, as depicted in
Fig. 6. This is consistent with the rating of the
importance of WCM shown in Fig. 5: the firms
have stated that WCM plays a more important
role as an internal funding source than as an
external funding source.
The analysis of the received answers shows
that the firms are well aware of the importance
and impact of the working capital management
on the overall performance. Furthermore, the
working capital management is seen as a
decisive factor and an important driver of the
company’s present and future performance.
Some of the most distinct answers are presented
below.
As shown in Fig. 5, the general importance
of WCM for the success of the company is
considered as relatively high with an average
rating of 4.29 on a scale ranging from 1 to 5, with
a higher number representing higher
importance. The firms see the highest impact
on the cash management: eight out of nine
companies have stated that the WCM is very
important for the cash management. This
certainly makes sense, since changes within the
working capital directly influence the timing of
the cash flows and hence a firm’s cash balance.
Another big influence is seen in the
profitability in the long run and the reduction
of tied-up capital. Those two are closely related
to each other, since (all other things being equal)
less capital leads to a higher profitability. On
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this time, in contrast to the receivables
management. The negotiating power can be
levered through the building of a central hub,
i.e. the centralization of all procurement
activities. This is especially important in the
chemical and pharmaceutical industry, where
business-to-business contacts are predominant
with regard to sourcing.
The inventories are the most complex
element of the working capital, and often require
the greatest effort in order for optimization.
Moreover, supply chains and corresponding
processes may vary substantially between the
different firms. It is therefore difficult to provide
general suggestions for all companies. A
successful strategy has to be developed with
regard to the firm’s structure and in collaboration
with the responsible operations and site
managers, among others. Modern inventory
management is supported by advanced IT
systems, and different scenarios can be
simulated with the aid of sophisticated
simulation tools (Adams, 2008). However, the
volatility of the oil price, and hence of the raw
material and energy prices for the chemical
industry, remains a challenge in the future. Lean
inventory management thus is likely to gain
further importance.
Besides the operational excellence, the
inventory level also highly depends on the
collaboration within the company, and within
the entire supply chain. The various involved
divisions within the company have to share their
information in order to optimize for instance
production schedules or safety stock levels.
Decisions and strategies should be developed
by integrating the sales, supply chain, production
and finance view. A holistic view of operating
decisions and its consequences is more likely to
succeed in the long term. Interdisciplinary, cross-
functional teams can be established to intensify
the integration.
In addition, the internal view has to be
extended to the whole supply chain (Rafuse,
1996). It is not sufficient to cooperate inside the
company. Instead, collaboration throughout the
entire supply chain should be aimed, which offers
considerable opportunities and competitive
advantages. True collaboration includes the
exchange of information about current and
future demand and supply levels, and the
working capital levels are intended to be lowered
throughout all members of the chain. The
reduction through better data exchange and
enhanced communication is more sustainable
and promises long-lasting benefits. Collaboration
leads to more responsive and resilient supply
Managerial implications
The very basic prerequisite of every
optimization within the working capital is the
management’s awareness of the benefits arising
from the improvements and the corresponding
will to implement the necessary actions and to
conduct the appropriate changes (Randall and
Farris, 2009). The com-mitment is thus a crucial
factor in the implementation of the appropriate
activities. Moreover, also the time period of the
improvement process highly relies on the
willingness of the top management: the higher
the commitment and importance given by the
top level executives, the earlier reductions in
net working capital occur. Besides being a top
priority at the upper level, it is essential that
the responsible divisions and managers are
informed and instructed appropriately. The best
strategic decisions do not lead to the desired
outcome if they are not implemented on the
operational level. Therefore good communication
is vital for the achievement of the set targets.
In addition, appropriate actions have to be
taken in order to ensure improvements within
the ac-counts receivable, inventories and
accounts payable. The launch of specific
initiatives with quantita-tive as well as
qualitative objectives often is a good way to
introduce changes in the culture and business
processes. Every element provides its own
opportunities for an improvement, and requires
more or less sophisticated strategies. With regard
to the accounts receivable, the negotiation of
the payment terms decisively influences the
collection period. Moreover, payment delays and
failures can be partly avoided by a profound
credit analysis of the customer. Other important
issues are consistent monitoring and a strict
dunning process. There are alternatives to the
conventional handling of the receivables, like
factoring or credit insurance. However, the
benefits of the outsourcing or insurance have
to exceed its costs.
An efficient management of the accounts
payable is based on a close monitoring of the
payment deadlines and potential trade
discounts. As long as no cash discount is offered,
the cash outflow should be postponed until the
due date. There is no benefit of an earlier cash
disbursement, and hence the full credit period
should be utilized. Cash discounts should be
used, if the benefits from the cash receipt are
bigger than the opportunity loss of the cash
outlay. Similar to the accounts receivable, the
payables level depends on the payment terms.
Of course, a longer payment period is favored
chains and that in turn results in lower overall
inventory requirements and higher efficiency.
Therefore, a paradigm shift is required from an
internal optimization of the processes to the
optimization of the whole supply chain. In the
light of the ongoing consolidation and
globalization within the chemical and
pharmaceutical industry, the supply chain
collaboration becomes an increasingly decisive
value driver.
The collaboration does not only offer chances
for an inventory optimization. Closer and more
intense relationships with customers and
suppliers may also enable a company to improve
its accounts receivable and payable, and
eventually to optimize the whole net working
capital.
Last but not least, a consistent and ongoing
monitoring and controlling ensures sustainable
im-provements, and can be supported and
enhanced by a benchmarking analysis and the
adaption of best practices.
Summary
The investigation of Swiss chemical and
pharmaceutical companies regarding their
working capital management has revealed the
huge potential which is lying in the management
of short term assets and liabilities. Furthermore,
the considerable differences between the single
firms show that an optimized working capital
management may play an important role for a
firm’s competitiveness. A successful working
capital strategy relies on the commitment and
awareness of the management and on efficient
working capital practices on the operative level.
In addition, internal and external collaboration
leads to more competitiveness, both for the firm
as well as for the whole supply chain. A
consistent and ongoing monitoring ensures
sustainable improvements, and can be supported
and enhanced by a benchmarking analysis and
the adaption of best practices.
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